253 related articles for article (PubMed ID: 15134519)
1. Recent advances in artemisinin and its derivatives as antimalarial and antitumor agents.
Jung M; Lee K; Kim H; Park M
Curr Med Chem; 2004 May; 11(10):1265-84. PubMed ID: 15134519
[TBL] [Abstract][Full Text] [Related]
2. C-16 artemisinin derivatives and their antimalarial and cytotoxic activities: syntheses of artemisinin monomers, dimers, trimers, and tetramers by nucleophilic additions to artemisitene.
Ekthawatchai S; Kamchonwongpaisan S; Kongsaeree P; Tarnchompoo B; Thebtaranonth Y; Yuthavong Y
J Med Chem; 2001 Dec; 44(26):4688-95. PubMed ID: 11741486
[TBL] [Abstract][Full Text] [Related]
3. Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy.
Posner GH; Paik IH; Sur S; McRiner AJ; Borstnik K; Xie S; Shapiro TA
J Med Chem; 2003 Mar; 46(6):1060-5. PubMed ID: 12620083
[TBL] [Abstract][Full Text] [Related]
4. Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers.
Posner GH; Ploypradith P; Parker MH; O'Dowd H; Woo SH; Northrop J; Krasavin M; Dolan P; Kensler TW; Xie S; Shapiro TA
J Med Chem; 1999 Oct; 42(21):4275-80. PubMed ID: 10543871
[TBL] [Abstract][Full Text] [Related]
5. Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents.
Chaturvedi D; Goswami A; Saikia PP; Barua NC; Rao PG
Chem Soc Rev; 2010 Feb; 39(2):435-54. PubMed ID: 20111769
[TBL] [Abstract][Full Text] [Related]
6. Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisinin.
Jeyadevan JP; Bray PG; Chadwick J; Mercer AE; Byrne A; Ward SA; Park BK; Williams DP; Cosstick R; Davies J; Higson AP; Irving E; Posner GH; O'Neill PM
J Med Chem; 2004 Feb; 47(5):1290-8. PubMed ID: 14971909
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P. falciparum malaria parasites and HL-60 cancer cells.
Chadwick J; Mercer AE; Park BK; Cosstick R; O'Neill PM
Bioorg Med Chem; 2009 Feb; 17(3):1325-38. PubMed ID: 19136263
[TBL] [Abstract][Full Text] [Related]
8. Heme as trigger and target for trioxane-containing antimalarial drugs.
Meunier B; Robert A
Acc Chem Res; 2010 Nov; 43(11):1444-51. PubMed ID: 20804120
[TBL] [Abstract][Full Text] [Related]
9. Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents.
Posner GH; McRiner AJ; Paik IH; Sur S; Borstnik K; Xie S; Shapiro TA; Alagbala A; Foster B
J Med Chem; 2004 Feb; 47(5):1299-301. PubMed ID: 14971910
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugs.
Mott BT; Tripathi A; Siegler MA; Moore CD; Sullivan DJ; Posner GH
J Med Chem; 2013 Mar; 56(6):2630-41. PubMed ID: 23425037
[TBL] [Abstract][Full Text] [Related]
11. Qinghaosu (artemisinin): chemistry and pharmacology.
Li Y
Acta Pharmacol Sin; 2012 Sep; 33(9):1141-6. PubMed ID: 22922345
[TBL] [Abstract][Full Text] [Related]
12. Artemisinin and Derivatives-Based Hybrid Compounds: Promising Therapeutics for the Treatment of Cancer and Malaria.
Peter S; Jama S; Alven S; Aderibigbe BA
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946603
[TBL] [Abstract][Full Text] [Related]
13. Artemisinin and its derivatives: an important new class of antimalarial agents.
Balint GA
Pharmacol Ther; 2001; 90(2-3):261-5. PubMed ID: 11578659
[TBL] [Abstract][Full Text] [Related]
14. Antimalarial activities of (+)-deoxoartemisitene and its novel C-11, 13 derivatives.
Jung M; Lee K; Jung H; Kendrick H; Yardley V; Croft SL
Bioorg Med Chem Lett; 2004 Apr; 14(8):2001-3. PubMed ID: 15050646
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of the antimalarial agent artemisinin. 8. design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria.
Avery MA; Muraleedharan KM; Desai PV; Bandyopadhyaya AK; Furtado MM; Tekwani BL
J Med Chem; 2003 Sep; 46(20):4244-58. PubMed ID: 13678403
[TBL] [Abstract][Full Text] [Related]
16. Synthetic chemistry fuels interdisciplinary approaches to the production of artemisinin.
Corsello MA; Garg NK
Nat Prod Rep; 2015 Mar; 32(3):359-66. PubMed ID: 25342519
[TBL] [Abstract][Full Text] [Related]
17. Biological Activities of Artemisinin Derivatives Beyond Malaria.
Liu X; Cao J; Huang G; Zhao Q; Shen J
Curr Top Med Chem; 2019; 19(3):205-222. PubMed ID: 30674260
[TBL] [Abstract][Full Text] [Related]
18. Total Synthesis and Biological Investigation of (-)-Artemisinin: The Antimalarial Activity of Artemisinin Is not Stereospecific.
Krieger J; Smeilus T; Kaiser M; Seo EJ; Efferth T; Giannis A
Angew Chem Int Ed Engl; 2018 Jul; 57(27):8293-8296. PubMed ID: 29723442
[TBL] [Abstract][Full Text] [Related]
19. Antitumour and antimalarial activity of artemisinin-acridine hybrids.
Jones M; Mercer AE; Stocks PA; La Pensée LJ; Cosstick R; Park BK; Kennedy ME; Piantanida I; Ward SA; Davies J; Bray PG; Rawe SL; Baird J; Charidza T; Janneh O; O'Neill PM
Bioorg Med Chem Lett; 2009 Apr; 19(7):2033-7. PubMed ID: 19249201
[TBL] [Abstract][Full Text] [Related]
20. Role of 2-Dimensional Autocorrelation Descriptors in Predicting Antimalarial Activity of Artemisinin and its Aanalogues: A QSAR Study.
Kalra S; Joshi G; Kumar R; Munshi A
Curr Top Med Chem; 2018; 18(31):2720-2730. PubMed ID: 30659538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
